Literature DB >> 16919776

Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project.

C A Stiller1, S S Bielack, G Jundt, E Steliarova-Foucher.   

Abstract

Data on 5572 children and adolescents diagnosed with malignant bone tumours (International Classification of Childhood Cancer, Group VIII) before the age of 20 years during 1978-1997 in Europe were extracted from the Automated Childhood Cancer Information System (ACCIS) database. Age-standardised incidence among children during the period 1988-1997 was similar for boys and girls aged 0-14 years (5.5-5.6 per million). Among adolescents aged 15-19 years, males had higher incidence (19.3 per million) than females (10.7 per million). Among children, osteosarcoma accounted for 51% of registrations and Ewing's sarcoma for 41%. Among adolescents, 55% of registrations were osteosarcoma and 28% Ewing's sarcoma. Both tumours had their highest incidence in late childhood or early adolescence. There were no significant time trends in incidence during 1978-1997. Five-year survival estimates for patients diagnosed during 1988-1997 were, respectively, 59% and 51% among children and adolescents with osteosarcoma and 62% and 30% among children and adolescents with Ewing's sarcoma. Between 1978-1982 and 1993-1997, survival increased for both children and adolescents with osteosarcoma, and for children with Ewing's sarcoma.

Entities:  

Mesh:

Year:  2006        PMID: 16919776     DOI: 10.1016/j.ejca.2006.05.015

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  76 in total

Review 1.  Promiscuous partnerships in Ewing's sarcoma.

Authors:  Savita Sankar; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2011-07

2.  Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.

Authors:  Jian Chen; Meng-xiong Sun; Ying-qi Hua; Zheng-dong Cai
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-31       Impact factor: 4.553

3.  Ewing's sarcoma: A case report of a 52-year-old woman with recurrent tumor and literature review.

Authors:  Waseem Khaliq; Mohammad Farshad Bahador; Thomas Nichols Laurence; Ronald Andrew Sapiente; James Sheridan Lewis; David Lee Graham
Journal:  Oncol Lett       Date:  2011-10-13       Impact factor: 2.967

4.  Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients.

Authors:  Roelof Koster; Orestis A Panagiotou; William A Wheeler; Eric Karlins; Julie M Gastier-Foster; Silvia Regina Caminada de Toledo; Antonio S Petrilli; Adrienne M Flanagan; Roberto Tirabosco; Irene L Andrulis; Jay S Wunder; Nalan Gokgoz; Ana Patiño-Garcia; Fernando Lecanda; Massimo Serra; Claudia Hattinger; Piero Picci; Katia Scotlandi; David M Thomas; Mandy L Ballinger; Richard Gorlick; Donald A Barkauskas; Logan G Spector; Margaret Tucker; D Hicks Belynda; Meredith Yeager; Robert N Hoover; Sholom Wacholder; Stephen J Chanock; Sharon A Savage; Lisa Mirabello
Journal:  Int J Cancer       Date:  2017-12-23       Impact factor: 7.396

5.  Ewing's Sarcoma Family Tumors in the Jaws: Case Report, Immunohistochemical Analysis and Literature Review.

Authors:  Ana Regina Casaroto; Marcelo Bonifacio DA Silva Sampieri; Cleverson Teixeira Soares; Paulo Sergio DA Silva Santos; Renato Yassutaka Faria Yaedu; José Humberto Damante; Vanessa Soares Lara
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

6.  The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002.

Authors:  Rachel Eyre; Richard G Feltbower; Peter W James; Karen Blakey; Emmanuel Mubwandarikwa; David Forman; Patricia A McKinney; Mark S Pearce; Richard J Q McNally
Journal:  BMC Cancer       Date:  2010-07-06       Impact factor: 4.430

7.  In vitro generation of cytotoxic T lymphocyte response using dendritic cell immunotherapy in osteosarcoma.

Authors:  Ye-Teng He; Qing-Min Zhang; Quan-Chun Kou; Bo Tang
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

Review 8.  RANKL/RANK/OPG: key therapeutic target in bone oncology.

Authors:  Kosei Ando; Kanji Mori; Francoise Rédini; Dominique Heymann
Journal:  Curr Drug Discov Technol       Date:  2008-09

9.  Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma.

Authors:  Enrique González-Billalabeitia; Ricardo Hitt; Jesús Fernández; Esther Conde; Francisco Martínez-Tello; Rafael Enríquez de Salamanca; Hernán Cortés-Funes
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

10.  Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma.

Authors:  Masanori Kawano; Kazuhiro Tanaka; Ichiro Itonaga; Tatsuya Iwasaki; Masashi Miyazaki; Shinichi Ikeda; Hiroshi Tsumura
Journal:  Oncol Lett       Date:  2016-02-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.